Dr Hellena Habte-Asres
LightNews LightNews
banner
drhellena1.bsky.social
Dr Hellena Habte-Asres
@drhellena1.bsky.social
260 followers 110 following 13 posts
Multi-Award-Winning Researcher in Diabetes & CKD | Clinical Academic Nurse & Epidemiologist | Advancing Innovation & Data-Driven Solutions to Improve Outcomes & Patient Experience.
Posts Replies Media Videos
Pinned
drhellena1.bsky.social
Dr Hellena Habte-Asres @drhellena1.bsky.social · Sep 26
Honoured to be named the winner of of the National BAME Health & Care Award 🏆 – Pioneering Health Research of the Year 2025. Sorry I couldn’t be there in person, but deeply grateful to colleagues, patients & PPIE partners who make this work possible🙏🏾
Reposted by Dr Hellena Habte-Asres
nnukrf.bsky.social
UK based HCPs allied to medicine working in diabetes, funds are available to support your professional development and patient benefit. Clinical Project funding up to £5000, UK based training and education funding and conference attendance.
Details and deadlines go to www.nnukrf.org.uk
The Novo Nordisk UK Research Foundation | NNUKRF
www.nnukrf.org.uk
October 8, 2025 at 8:14 AM
drhellena1.bsky.social
Honoured to be named the winner of of the National BAME Health & Care Award 🏆 – Pioneering Health Research of the Year 2025. Sorry I couldn’t be there in person, but deeply grateful to colleagues, patients & PPIE partners who make this work possible🙏🏾
September 26, 2025 at 8:25 AM
drhellena1.bsky.social
link.growkudos.com/1e74z204ykg
Bringing Care Together: The Role of Diabetes Kidney Nurses
This article explains the important role of a diabetes renal nurse (DRN) a specialist nurse who looks after people living with both diabetes and chronic kidney disease (CKD). These two conditions are...
link.growkudos.com
June 13, 2025 at 12:36 PM
drhellena1.bsky.social
Publication Alert 📢

"Beyond vision: The emotional toll of advanced diabetic retinopathy" 🧠👁️

We spotlight the emotional impact of vision-threatening DR — too often overlooked in care.👇🏾

doi.org/10.1111/dme....

@eye-surgeon-eve.bsky.social @crosbynwaobi.bsky.social
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library
Click on the article title to read more.
doi.org
May 27, 2025 at 8:57 AM
Reposted by Dr Hellena Habte-Asres
trishgreenhalgh.bsky.social
New report from UK Healthcare Services Safety Investigations Body (HSSIB): People with long term conditions are being harmed because care is fragmented and care coordinator roles are suboptimal. #healthpolicy #medsky

www.hssib.org.uk/patient-safe...
Workforce and patient safety: primary and community care co-ordination for people with long-term conditions
This is the fourth of five investigation reports that consider how working conditions in the NHS can be optimised to support patient safety, while maintaining and improving staff wellbeing.
www.hssib.org.uk
April 11, 2025 at 6:47 AM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
📣Team output led by Dr Usman Shah from the University of Lincoln. 'Optimisation of care among patients with diabetes mellitus & acute coronary syndrome through a specialised cardiodiabetes service—A registry study'. 👇 👇 #Diabetes #Cardiovascular
onlinelibrary.wiley.com/doi/full/10....
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library
Aims Diabetes mellitus remains a prevalent condition worldwide and a significant risk factor for atherosclerotic cardiovascular disease. Recent evidence suggests the use of glucose-lowering therapie.....
onlinelibrary.wiley.com
April 3, 2025 at 5:25 PM
Reposted by Dr Hellena Habte-Asres
kidneyresearchuk.org
A new publication has been published in collaboration with Breakthrough T1D UK and Diabetes UK to identify six key research and healthcare priorities to tackle diabetic kidney disease (#DKD).

Read more: www.kidneyresearchuk.org/2025/03/05/u...

#Diabetes #KidneyDisease
www.kidneyresearchuk.org
March 5, 2025 at 12:08 PM
drhellena1.bsky.social
@dnpsofcolor.bsky.social @drannamvaldez.bsky.social @calvinmoorley.bsky.social @gemmaclunie.bsky.social @drmccamey.bsky.social 👇🏾
standupforscience.bsky.social Stand Up for Science! @standupforscience.bsky.social · Feb 12
Welcome to the Bluesky account for Stand Up for Science 2025!

Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide!

#scienceforall #sciencenotsilence
March 3, 2025 at 9:29 AM
drhellena1.bsky.social
Great two days at #DUK2025!

Loved catching up with colleagues & chairing a session 🎤. A highlight was Prof. Wheeler discussing our integrated diabetes care model for people with advanced CKD in NCL 🏥💙.

Grateful for the inspiring conversations—excited to keep the momentum going!
March 2, 2025 at 6:48 PM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Our special issue for DiabeticMedicine entitled 'From Bench to Bedside: An integrated and multi-disciplinary approach to tackling diabetic kidney disease' is available online now. 👇👇 #KidneyDisease #Diabetes #NephSky #KidneyResearch #Diabetes #CardioSky

onlinelibrary.wiley.com/toc/14645491...
<em>Diabetic Medicine</em> | Diabetes UK Journal | Wiley Online Library
Click on the title to browse this issue
onlinelibrary.wiley.com
January 16, 2025 at 4:29 PM
Reposted by Dr Hellena Habte-Asres
paulsquires.bsky.social
Great read to start 2025 #GLP1 #semaglutide #diabetes #diabetesuk #cardiorenal #GLP1RA
www.thelancet.com/journals/lan...
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.
www.thelancet.com
January 2, 2025 at 5:21 PM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Diabetic kidney disease: the four pillars of therapy 👩‍🔬🥼🧪👨‍🔬 #Diabetes #Kidneydisease #Cardiovascular #SGLT2i #GLP-1 #NelhSky #CardioSky 👇👇👇

medicinetoday.com.au/mt/2024/dece...
Diabetic kidney disease: the four pillars of therapy | Medicine Today
medicinetoday.com.au
December 28, 2024 at 9:40 PM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes & diabetic kidney disease: post hoc analyses of the RENAAL & IDNT trials #NephSky #CardioSky #KidneyDisease #diabetes 👇👇

link.springer.com/article/10.1...
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENA...
Aims/hypothesis Our aim was to assess sex differences in the efficacy of angiotensin receptor blockers (i.e. losartan and irbesartan) on kidney and cardiovascular outcomes in individuals with type 2 d...
link.springer.com
December 16, 2024 at 8:21 AM
Reposted by Dr Hellena Habte-Asres
kidneyresearchuk.org
What better way to kick off our journey here than by raising awareness about kidney health? Let’s start by highlighting the main symptoms of kidney disease.

Early diagnosis is key to managing and slowing progression of kidney failure.

For more information on symptoms, click here: bit.ly/3z7fsVi
Fuchsia and purple ombré background with the wording 'What are the symptoms of kidney disease?' in bold white writing. At the bottom is an arrow prompting the user to go on to the next image. Fuchsia and purple ombré background with the wording 'Kidney disease is often referred to as the ‘silent killer’. Early stages of kidney disease are not easy to detect and usually picked up on routine test e.g. blood or urine test.' Another arrow sits at the bottom right. Fuchsia and purple ombré background with the wording 'However, signs for advanced kidney disease are:' and lists 16 bullet points including dry skin, itching, muscle cramps, shortness of breath and bone or joint pain. An arrow sits at the bottom of the page. Fuchsia and purple ombré background with the wording "If you are experiencing any of these symptoms, arrange an appointment with your GP." End of images.
December 9, 2024 at 11:45 AM
Reposted by Dr Hellena Habte-Asres
dnpsofcolor.bsky.social
It's #GIVINGTUESDAY!!! Help us reach the goal of $3,000! Every amount counts. Unable to give? Consider sharing this post, our facebook fundraiser, and the link to our donation page: www.dnpsofcolor.org/donate or Facebook fundraiser:
www.facebook.com/donate/13005...
Thank you!
December 3, 2024 at 12:42 PM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trial 👩‍🔬🥼🧪 #cardioSky #NephSky #kidneyDisease #Diabetes #Nephropathy #CKD #MedSky #GLP-1 👇👇👇

www.thelancet.com/journals/lan...
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
We found evidence that GLP-1 receptor agonists significantly reduce clinically important kidney events, kidney failure, and cardiovascular events.
www.thelancet.com
November 27, 2024 at 7:31 PM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants 👩‍🔬🔬🥼 #Diabetes #Type1diabetes #Type2diabetes #MedSky #Lancet
Full details 👇
www.thelancet.com/journals/lan...
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
In most countries, especially in low-income and middle-income countries, diabetes treatment has not increased at all or has not increased sufficiently in comparison with the rise in prevalence. The bu...
www.thelancet.com
November 26, 2024 at 6:31 PM
Reposted by Dr Hellena Habte-Asres
paulsquires.bsky.social
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) #diabetes #T2DM #type2diabetes #MedSky 👇👇

www.thelancet.com/journals/lan...
Young adult-onset type 2 diabetes heralds a poor prognosis
Younger-onset type 2 diabetes is rapidly increasing in prevalence, with the majority presenting in adulthood aged 18–39 years.1 This change in diabetes topography presents a challenge to health-care p...
www.thelancet.com
November 27, 2024 at 1:46 PM
drhellena1.bsky.social
Thrilled to be speaking at the upcoming Diabetes Africa Forum where we’ll be tackling vital issues in eye and kidney health in Black communities 👁️🩺🫁

I’ll be joined by an incredible panel: Prof @crosbynwaobi.bsky.social, Dr Janaka Karalliedde @eye-surgeon-eve.bsky.social
November 27, 2024 at 10:03 AM
drhellena1.bsky.social
📢 Adults with Type 1 Diabetes: Join the #MyREMEDY study testing MyDiaMate, a web-based self-help programme to improve mental health.

Available in 🇬🇧🇳🇱🇩🇪🇪🇸, it covers stress, low mood, fatigue & more.

Learn more👇🏾

www.kcl.ac.uk/research/myr...
📩 MyREMEDY@kcl.ac.uk
The Effectiveness of MyDiaMate, a Self-guided Web-based App for Mental Health in Type 1 Diabetes: a Multinational Randomized Controlled Trial
MyREMEDY (MyDiaMate for REMission of Elevated Diabetes Distress in tYpe 1 diabetes).
www.kcl.ac.uk
November 25, 2024 at 6:46 PM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Estimated Lifetime Cardiovascular, Kidney, & Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, & Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes & Albuminuria 👩‍🔬🥼 #NephSky #CardioSky

👇👇👇
www.ahajournals.org/doi/10.1161/...
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patie...
BACKGROUND: Sodium glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and the nonsteroidal mineralocorticoid receptor antagonist (ns-MRA) finerenone all...
www.ahajournals.org
November 22, 2024 at 9:00 AM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes 👩‍🔬🥼🔬🧪. #CardioSky #NephSky #Cardiovascular #cardiorenal #diabetes

@diabetologiajnl.bsky.social 👇👇👇

link.springer.com/article/10.1...
Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes - Diabetologia
Aims/hypothesis Prediabetes (HbA1c 39–47 mmol/mol [5.7–6.4%] or fasting glucose 5.6–6.9 mmol/l) is associated with elevated risks of microvascular and macrovascular complications. It is unknown to wha...
link.springer.com
November 21, 2024 at 12:59 PM
Reposted by Dr Hellena Habte-Asres
rogerkline.bsky.social
One of my favourite books. Packed with evidence that compassion is good for others and good for you. www.compassionomics.com
Home
Compassionomics provides the evidence that one simple tool, compassion, can affect not only the outcomes for our patients, but also the financial health of our…
www.compassionomics.com
November 19, 2024 at 7:15 AM
Reposted by Dr Hellena Habte-Asres
chillslincoln79.bsky.social
📣Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity 👇👇 #cardiovascular #cardiosky #Obesity #diabetes #GLP-1 #heartfailure

www.nejm.org/doi/full/10....
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...
www.nejm.org
November 16, 2024 at 3:18 PM